Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "virus replication process (host-directed)" refers to therapeutic strategies aimed at disrupting viral reproduction by interfering with essential—but non-vital—host functions exploited during infection. This approach targets cellular factors or pathways utilized by viruses, such as lipid metabolism, kinases, or immune response regulators, rather than directly attacking viral components. Host-directed antivirals offer potential advantages, including a lower likelihood of resistance development and broad-spectrum applicability, but require careful selection of targets to minimize off-target effects and the risk of viral adaptation.
Inhibition of host factors or pathways essential for virus replication, assembly, or release; modulation of host immune response.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Virus Replication Process (Host-Directed) (HDA).